Cargando…

Leuconostoc pseudomesenteroides-associated hemophagocytic syndrome: A case report

Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory syndrome characterized by fever, pancytopenia and splenomegaly. The underlying hemophagocytosis occurs primarily in the bone marrow, liver and lymph nodes. Multiple microbiological agents, including cytomegalovirus, Epstein-Barr vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xinfeng, Jiang, Qilong, Liu, Jiduo, Zhao, Fu, Chen, Weitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776167/
https://www.ncbi.nlm.nih.gov/pubmed/29434707
http://dx.doi.org/10.3892/etm.2017.5519
_version_ 1783294029350305792
author Lin, Xinfeng
Jiang, Qilong
Liu, Jiduo
Zhao, Fu
Chen, Weitao
author_facet Lin, Xinfeng
Jiang, Qilong
Liu, Jiduo
Zhao, Fu
Chen, Weitao
author_sort Lin, Xinfeng
collection PubMed
description Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory syndrome characterized by fever, pancytopenia and splenomegaly. The underlying hemophagocytosis occurs primarily in the bone marrow, liver and lymph nodes. Multiple microbiological agents, including cytomegalovirus, Epstein-Barr virus and Mycobacterium tuberculosis, have been implicated in the pathogenesis of HLH. The present study presents a case of HLH associated with Leuconostoc pseudomesenteroides infection treated successfully with clindamycin. A 33-year-old man presented with recurrent episodes of fever and diarrhea. Upon initial treatment at another hospital (the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China), blood chemistry analysis demonstrated moderate anemia (hemoglobin 88 g/l; reference range, 120.0–160.0), elevated ferritin (1,068.47 mg/l; reference range, 21.81–274.66), total bilirubin (392.4 mmol/l; reference range, 5.1–28.0), conjugated bilirubin (335.7 mmol/l; reference range, 0–10.0), and γ-glutamyl transpeptidase (150 U/l; reference range, 10–60). The patient was treated with antibiotics for suspected pneumonia and cholecystitis, but new symptoms (including diarrhea and inflammatory colitis) started to emerge. The patient was subsequently treated with ganciclovir (5 mg/kg/day for 1 month), but body temperature increased to 41.0°C. Upon transferring to our hospital, the patient had severe anemia (hemoglobin, 39 g/l; red blood cell, 1.61×10(12)/l; reference range, 4.0–5.5×10(12)/l). Jaundice was apparent: Total bilirubin, 299.5 mmol/l; conjugated bilirubin, 215.7 mmol/l. The patient was treated with clindamycin (150 mg, taken orally every 12 h for 1 week) and supportive care that included parenteral nutrition. Symptoms rapidly dissipated after the treatment. Blood chemistry analysis 5 days after the first dose of clindamycin revealed substantial improvement in anemia and jaundice. The patient requested discharge for financial reasons, but continued treatment (details not available) at a local hospital (Pengpai Memorial Hospital, Shanwei, China). Upon a visit to our hospital 8 months later, the patient has no notable complaints, with the exception of moderate anemia. The present case suggests that HLH may be associated with L. pseudomesenteroides infection.
format Online
Article
Text
id pubmed-5776167
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57761672018-02-12 Leuconostoc pseudomesenteroides-associated hemophagocytic syndrome: A case report Lin, Xinfeng Jiang, Qilong Liu, Jiduo Zhao, Fu Chen, Weitao Exp Ther Med Articles Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory syndrome characterized by fever, pancytopenia and splenomegaly. The underlying hemophagocytosis occurs primarily in the bone marrow, liver and lymph nodes. Multiple microbiological agents, including cytomegalovirus, Epstein-Barr virus and Mycobacterium tuberculosis, have been implicated in the pathogenesis of HLH. The present study presents a case of HLH associated with Leuconostoc pseudomesenteroides infection treated successfully with clindamycin. A 33-year-old man presented with recurrent episodes of fever and diarrhea. Upon initial treatment at another hospital (the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China), blood chemistry analysis demonstrated moderate anemia (hemoglobin 88 g/l; reference range, 120.0–160.0), elevated ferritin (1,068.47 mg/l; reference range, 21.81–274.66), total bilirubin (392.4 mmol/l; reference range, 5.1–28.0), conjugated bilirubin (335.7 mmol/l; reference range, 0–10.0), and γ-glutamyl transpeptidase (150 U/l; reference range, 10–60). The patient was treated with antibiotics for suspected pneumonia and cholecystitis, but new symptoms (including diarrhea and inflammatory colitis) started to emerge. The patient was subsequently treated with ganciclovir (5 mg/kg/day for 1 month), but body temperature increased to 41.0°C. Upon transferring to our hospital, the patient had severe anemia (hemoglobin, 39 g/l; red blood cell, 1.61×10(12)/l; reference range, 4.0–5.5×10(12)/l). Jaundice was apparent: Total bilirubin, 299.5 mmol/l; conjugated bilirubin, 215.7 mmol/l. The patient was treated with clindamycin (150 mg, taken orally every 12 h for 1 week) and supportive care that included parenteral nutrition. Symptoms rapidly dissipated after the treatment. Blood chemistry analysis 5 days after the first dose of clindamycin revealed substantial improvement in anemia and jaundice. The patient requested discharge for financial reasons, but continued treatment (details not available) at a local hospital (Pengpai Memorial Hospital, Shanwei, China). Upon a visit to our hospital 8 months later, the patient has no notable complaints, with the exception of moderate anemia. The present case suggests that HLH may be associated with L. pseudomesenteroides infection. D.A. Spandidos 2018-02 2017-11-16 /pmc/articles/PMC5776167/ /pubmed/29434707 http://dx.doi.org/10.3892/etm.2017.5519 Text en Copyright: © Lin et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Lin, Xinfeng
Jiang, Qilong
Liu, Jiduo
Zhao, Fu
Chen, Weitao
Leuconostoc pseudomesenteroides-associated hemophagocytic syndrome: A case report
title Leuconostoc pseudomesenteroides-associated hemophagocytic syndrome: A case report
title_full Leuconostoc pseudomesenteroides-associated hemophagocytic syndrome: A case report
title_fullStr Leuconostoc pseudomesenteroides-associated hemophagocytic syndrome: A case report
title_full_unstemmed Leuconostoc pseudomesenteroides-associated hemophagocytic syndrome: A case report
title_short Leuconostoc pseudomesenteroides-associated hemophagocytic syndrome: A case report
title_sort leuconostoc pseudomesenteroides-associated hemophagocytic syndrome: a case report
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776167/
https://www.ncbi.nlm.nih.gov/pubmed/29434707
http://dx.doi.org/10.3892/etm.2017.5519
work_keys_str_mv AT linxinfeng leuconostocpseudomesenteroidesassociatedhemophagocyticsyndromeacasereport
AT jiangqilong leuconostocpseudomesenteroidesassociatedhemophagocyticsyndromeacasereport
AT liujiduo leuconostocpseudomesenteroidesassociatedhemophagocyticsyndromeacasereport
AT zhaofu leuconostocpseudomesenteroidesassociatedhemophagocyticsyndromeacasereport
AT chenweitao leuconostocpseudomesenteroidesassociatedhemophagocyticsyndromeacasereport